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Abstract The transcription factor Pdr1p recognizes Pdr1p/
Pdr3p-response element (PDRE) to activate genes involved in
multidrug resistance of the budding yeast. To identify novel
targets of Pdr1p, we compared transcriptomes among the yeast
cells bearing wild, disrupted and gain-of-function alleles of PDR1
using a high-throughput fluorescent differential display PCR.
Consequently, we identified 20 transcripts apparently regulated
by Pdr1p, which are derived from well-known target genes as
well as those that have never been described in the context of
drug resistance. Intriguingly, among the latter, a previously
unrecognized gene bearing a small putative open reading frame
preceded by a functional PDRE was found. ß 2001 Published
by Elsevier Science B.V. on behalf of the Federation of Euro-
pean Biochemical Societies.
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1. Introduction
The budding yeast Saccharomyces cerevisiae serves as an
excellent model for higher eukaryotic cells in various aspects
of molecular cell biology. It is also the case for multiple drug
resistance, one of the most serious issues in cancer chemo-
therapy. The studies on drug-resistance mutants of the yeast
have revealed that many genes control multiple or pleiotropic
drug resistance (PDR) phenomenon through the formation of
the PDR network [1]. Among these genes, PDR1 plays a key
role. The product of PDR1 is a transcription factor belonging
to Cys2His6-type zinc-¢nger protein [2]. Both Pdr1p and its
homolog Pdr3p [3] bind to a characteristic sequence called
Pdr1p/Pdr3p-response element (PDRE), whose consensus is
TCCGCGGA, and activate the transcription of genes £anking
the element [4^10].
The target genes for Pdr1p/Pdr3p include those for ATP
binding cassette (ABC) protein superfamily, such as PDR5
[4,5,11], SNQ2 [7,12,13], YOR1 [10,14,15], PDR10 [9,15] and
PDR15 [9,15]. The products of these genes function as e¥ux
pumps for various drugs. Accordingly, gain-of-function muta-
tions in PDR1 increase the amounts of these proteins to con-
fer PDR phenotype, whereas the cells with compromised
Pdr1p activity show hypersensitivity to various drugs [1]. It
is reported that HXT9 and HXT11, members of the major
facilitator superfamily (MFS), are also regulated by PDR1/
PDR3 [8]. Intriguingly, in contrast with the ABC proteins,
the deletion, but not the overexpression, of these MFS genes
confers drug resistance. In addition to these membrane pro-
teins, the expression of PDR3 is auto-regulated by Pdr1p/
Pdr3p [6].
While the transcription factor Pdr1p has been well charac-
terized and its binding consensus sequence was identi¢ed, its
downstream targets have not been fully explored. We thus
launched a comparative transcriptome analysis, in which the
expression level of each gene is compared among the yeast
cells bearing wild-type, disrupted and gain-of-function alleles
of PDR1. The target of Pdr1p would be down-regulated in
pdr1v strains and/or induced in cells with enhanced Pdr1p
activity provided by gain-of-function alleles. We thus search
such transcripts using a high-throughput £uorescent di¡eren-
tial display (FDD) PCR.
2. Materials and methods
2.1. FDD analysis
The three yeast strains used in the transcriptome analysis were
FY1679-28C (MATa, PDR1, PDR3, ura3-52, leu2v1, trp1v63,
his3v200), FY1679-28C/TDEC (MATa, pdr1v2: :TRP1, pdr3v : :
HIS3, ura3-52, leu2v1, trp1v63, his3v200) and EC61 (MATa,
PDR1-3, pdr3v : :HIS3, ura3-52, leu2v1, trp1v63, his3v200), each
bearing a wild-type, a null and a gain-of-function allele of PDR1
[16]. Following the growth in YPAD (1% yeast extract, 2% peptone,
0.004% adenine sulfate, 2% glucose) at 30‡C for 16 h, each strain was
diluted with YPAD to OD600nm = 0.5, cultured for an additional 2 h at
30‡C and harvested for RNA isolation. Total RNAs were isolated
from each strain using the modi¢ed hot-phenol method [17]. The
extracted RNAs were treated with RNase-free DNase I to remove
residual contaminating DNAs and further puri¢ed by acid-guanidine
thiocyanate-phenol-chloroform method using TRIzol LS reagent
(Gibco BRL).
FDD analysis was performed using the protocol S described pre-
viously [18^20]. Di¡erentially displayed cDNA bands were excised
from the gel, re-ampli¢ed and subjected to direct cycle sequencing
with the £uorescent anchor primers. The cDNA fragments refractory
to direct sequencing were cloned into a ‘T-vector’ and analyzed as
described previously [18^20]. The expression level of each candidate
target was compared among the strains using a modi¢ed adapter-
tagged competitive PCR technique [21]. The promoter regions of
the candidate targets were analyzed by YEBISU to search conserved
sequence motifs [22].
2.2. Characterization of YPR036W-A
To reveal the structure of YPR036W-A transcript, 5P-RACE (rapid
ampli¢cation of cDNA ends) and 3P-RACE were performed as de-
scribed previously [23]. For L-galactosidase assays, we fused a 734-bp
fragment, which spans the promoter and the ¢rst 7 codons, with the
lacZ gene on a newly constructed vector pRS41K, a pRS416-deriva-
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tive bearing KanMX instead of URA3, to obtain pRS41K-YPR036W-
A-lacZ. We replaced the PDRE-like sequence (TCCGCGGA) of this
plasmid with an NcoI site (CCATGG) to obtain pRS41K-YPR036W-
A-PDREv-lacZ. Using the pop-in^pop-out technique described pre-
viously [24], we replaced the PDRE-like sequence of FY1679-28C with
an NcoI site, thereby generating FY1679-28Cd. The PDR1 and PDR3
of FY1679-28Cd were replaced with pdr1v2: :TRP1 and pdr3v: :HIS3
alleles, both ampli¢ed from FY1679-28C, to obtain FY1679-28Cd/
TDEC. We used the gap-repair cloning technique to recover PDR1
and PDR1-3, with their upstream (1200 bp) and downstream (600 bp)
sequences, from FY1679-28C and EC61, respectively, to pRS41K for
episomal expression of these genes.
3. Results and discussion
3.1. FDD analysis of pdr1 mutants
To identify potential target genes for the transcription fac-
tor Pdr1p, we intended to compare transcripts among three
yeast strains, namely FY1679-28C (a wild-type strain for
PDR1), FY1679-28C/TDEC (a pdr1v strain) and EC61
(a strain bearing a gain-of-function allele PDR1-3) [16]. These
strains with di¡erential Pdr1p activities were cultured in a rich
medium, and total RNAs were isolated at the late logarithmic
growth phase. The puri¢ed total RNAs were analyzed by
FDD (Fig. 1), which we had established as a highly reliable
message display PCR method with unsurpassed speed and
operational safety [18^20]. In this analysis, we tested 174
primer combinations (i.e. three anchor primers U58 arbitrary
primers), which should cover V90% of the 6000 yeast genes if
we assume that all the transcripts can be detected by FDD
and that the sampling by arbitrary primers is completely ran-
dom [19]. We performed two independent FDD analyses us-
ing di¡erent batches of RNAs, each of which imagedV18 000
cDNA bands. Of these, 80 fragments were reproducibly dis-
played more intensely in the strain with enhanced Pdr1p ac-
tivity and/or more weakly in the pdr1v strain than in the other
two.
3.2. Con¢rmation of di¡erential expression
We succeeded in revealing the identities of 72 out of the
80 bands described above. These sequences contained those
apparently derived from di¡erent portions of the same tran-
script: removal of such redundancy left 23 independent mes-
sages. We then con¢rmed their expression pattern by adapter-
Fig. 1. A typical FDD pattern is shown, which compared tran-
scripts from three yeast strains with di¡erential Pdr1p activity (W,
wild PDR1 ; v, pdr1v ; O, PDR1-3) using ¢ve di¡erent primer com-
binations. The arrows indicate cDNA bands induced in the strain
with enhanced Pdr1p activity (O).
Table 1
Induction of potential target genes of Pdr1p
ORF name Gene name Expression level
PDR1 (FY1679-28C) pdr1v (FY1679C-28C/TDEC) PDR1-3 (EC61)
YAL066W 1.0 0.4 1.0
YBR145W ADH5 1.0 0.5 1.9
YBR256C RIB5 1.0 0.8 1.6
YCL030C HIS4 1.0 1.3 3.1
YDL020C RPN4 1.0 0.5 2.7
YDR011W SNQ2 1.0 0.6 7.8
YGL209W MIG2 1.0 0.9 3.4
YGL224C SDT1 1.0 0.8 1.7
YGR254W ENO1 1.0 0.8 2.1
YGR281W YOR1 1.0 0.6 17.8
YHR071W PCL5 1.0 0.6 1.5
YHR162W 1.0 0.7 1.7
YLR044C PDC1 1.0 0.9 1.7
YMR062C ECM40 1.0 1.4 2.3
YMR102C 1.0 0.4 1.9
YNL231C PDR16 1.0 0.8 6.4
YOR153W PDR5 1.0 0.0 10.0
YOR303W CPA1 1.0 0.7 2.1
YPR036W-A 1.0 0.9 4.3
YPR145W ASN1 1.0 0.7 1.9
Relative expression ratio for each gene was quanti¢ed using an adopter-tagged competitive PCR method among the three strains. The expres-
sion level in the wild-type cell is taken as 1.
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tagged competitive PCR [21], a highly sensitive method to
quantify the ratio of expression levels, using gene-speci¢c
primers derived from open reading frames (ORFs) lying up-
stream of the identi¢ed cDNA fragments (Fig. 2, Table 1). In
19 out of the 23 cases, the expression of each upstream ORF
showed good correlation with the FDD pattern, thereby dem-
onstrating the reliability of our approach.
3.3. Candidates for targets of Pdr1p
The 19 genes identi¢ed as above include PDR5, SNQ2
andYOR1 (Table 1). These three are the most well-established
targets of PDR1 encoding members of ABC superfamily.
Identi¢cation of these major targets as well as a recently iden-
ti¢ed one, PDR16 [25], proved the principle of our approach.
On the other hand, we failed to detect other target genes,
namely HXT9, HXT11, PDR10 and PDR15 [8,9]. Retrospec-
tive analysis of our failure in detecting these genes suggested
that our arbitrary primers would not hit them at all or could
hit, but at a position too distant from the 3P-ends to be am-
pli¢ed by PCR (not shown). These results demonstrated the
limitation inherent to the sampling by arbitrarily selected
primers. The genes other than these four are those that have
never been described in the context of drug resistance. Their
biochemical characters are so divergent that it is di⁄cult to
draw a simplistic explanation for their induction by Pdr1p.
To identify potential regulatory signals, we analyzed the
upstream 600-bp regions of the identi¢ed targets using YEBI-
SU program [22]. To our interest, the candidate regulatory
element predicted with the highest score was exactly matched
to the PDRE (Tables 2A,B). In addition to the four known
targets mentioned above, RIB5, HIS4, RPN4, MIG2, CPA1
and ASN1 were found to contain PDRE or its variants. We
also noticed that YMR102C has a PDRE at the positions
3607 to 3598. The other genes, that lack apparent PDREs,
would not be the primary targets for Pdr1p, but are induced
indirectly. However, to discriminate between primary and in-
direct targets, much ¢ner expression analyses using condition-
al mutants and/or genome-wide chromatin immunoprecipita-
tion analyses [26] will be necessary.
During the course of this work, DeRisi et al. [27] reported
DNA microarray analysis of FY1679-28C/TDEC cells with or
without episomal PDR1-3 [27]. The genes activated by PDR1-
3 in their study do not include all of the targets that we
identi¢ed. In addition, our microarray analysis revealed that
some of the targets identi¢ed in their report fail to show high-
er expression in EC61 than in others. Notably, most targets
identi¢ed in both studies are those bearing typical PDREs,
whereas those lacking the element are barely shared between
the two (M. Onda et al., in preparation). Similarly, recent
microarray experiments [28] comparing the presence and ab-
sence of PDR1-3 observed no signi¢cant induction for eight of
the previously suggested targets, seven of which bear no
PDREs. Intriguingly, this study revealed eight novel candi-
dates for Pdr1p-targets including RPN4 and YMR102C [28],
both of which were identi¢ed also in our FDD analysis and
associated with PDREs (Table 1).
Inconsistency among the results of these studies may be
partly due to the di¡erence in strain and culture conditions;
we did ¢nd that some of the identi¢ed targets are expressed
much more abundantly in synthetic media and hence the in-
Fig. 2. Quanti¢cation of target gene induction by ATAC-PCR. The
expression patterns of targets revealed by the FDD analysis were
examined by a modi¢ed adapter-tagged competitive PCR [21]. Two
examples, one for the established target PDR5 and the other for a
novel target MIG2, are shown. The upper and lower panels show
gel patterns and electropherogram, respectively. Each PCR band is
derived from the indicated strain (W, wild PDR1 ; v, pdr1v ; Ov,
PDR1-3), and their ratios quanti¢ed by GeneScan analysis software
are summarized in Table 1.
Table 2A
PDRE-like elements extracted by YEBISU
ORF name Gene name Position/sequence Score
YBR256C RIB5 3591 AACCACGGAG 3582 9.68
YBR256C RIB5 3124 TTCCATGGAG 3115 13.85
YCL030C HIS4 3413 AGCCGTGGAA 3404 13.07
YDL020C RPN4 3443 TTCCGTGGAA 3434 15.95
YDL020C RPN4 3400 TTCCACGGAT 3391 12.55
YDR011W SNQ2 3585 TTCCGCGGAT 3576 13.78
YGL209W MIG2 3328 ATCCGCGGAG 3319 14.49
YGL209W MIG2 3316 ATCCACGGAG 3307 13.26
YGR281W YOR1 3402 TTCCGTGGAA 3393 15.95
YGR281W YOR1 3349 ACCCGTGGAA 3340 13.07
YNL231C PDR16 3494 AGCCACGGAA 3485 12.14
YNL231C PDR16 3423 TTCCGCGGAG 3414 15.36
YOR153W PDR5 3564 GTCCGTGGAG 3555 11.61
YOR153W PDR5 3535 TCCCACGGAA 3526 13.01
YOR153W PDR5 3492 TTCCGCGGAA 3483 16.23
YOR153W PDR5 3376 TTCCGTGGAA 3367 15.95
YOR153W PDR5 3314 CTCCGCGGAA 3305 12.78
YOR303W CPA1 3501 TCCCGTGGAA 3492 13.95
YPR145W ASN1 3332 TGCCGTGGAC 3323 10.49
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duction e¡ect of PDR1-3 is apparently blurred (unpublished
observation). One may thus e⁄ciently identify bona ¢de tar-
gets by searching genes similarly induced regardless of exper-
imental conditions.
3.4. A novel tiny gene YPR036W-A induced by Pdr1p
As mentioned above, ATAC-PCR assays using ORF prim-
ers failed to con¢rm di¡erential expression patterns for four
cDNA bands. However, for two of the four, RT-PCR assays
using primers designed within the cDNA bands reproduced
the induced expression patterns in the strain with enhanced
Pdr1p activity (Fig. 4B). Both of these fragments were derived
from the intergenic region between VMA13/YPR036W and
ERV2/YPR037C (Fig. 4A), and RT-PCR assays revealed
that they are derived from a single transcript (not shown).
We thus hypothesized a hitherto overlooked transcription
unit lying in this region.
To know the direction of this transcript, we performed
strand-speci¢c RT-PCR assays, in which the cDNA is synthe-
sized with one of the speci¢c primers and subsequently used as
the template for PCR with both primers. If the oligonucleo-
tide used in the reverse-transcription step is of anti-sense di-
rection as to the transcript, it would prime the ¢rst-strand
synthesis, and hence RT-PCR product would be obtained.
In contrast, if it is of the sense orientation, nothing would
be ampli¢ed. The results of such strand-speci¢c RT-PCR as-
says clearly indicated that the RNA is transcribed in the di-
rection from VMA13/YPR036W to ERV2/YPR037C (Fig.
4C). We next performed 5P- and 3P-RACE to reveal the entire
structure of this transcript. Since the predicted transcript does
not have any ORF longer than 100 amino acids, it had not
been identi¢ed as a gene in the conventional annotation of the
budding yeast genome sequence. However, it has an ORF
composed of 68 residues and we designated this gene as
YPR036W-A.
3.5. PDRE regulating the expression of YPR036W-A
Intriguingly,YPR036W-A has a consensus PDRE sequence
Table 2B
Consensus sequence for the PDRE-like element extracted by YEBISU
Position
1 2 3 4 5 6 7 8 9 10
A 32 5 0 0 30 0 0 0 100 55
C 5 16 100 100 0 55 0 0 0 5
G 5 16 0 0 70 0 100 100 0 30
T 58 63 0 0 0 45 0 0 0 10
Consensus T T C C G C G G A A
C
Fig. 3. A novel transcription unit lying between VMA13 and ERV2.
A: Six FDD fragments mapped to the intergenic region between
VMA13/YPR036W and ERV2/YPR037C. B: Comparison among
the FDD pattern and RT-PCR patterns for VMA13/YPR036W,
ERV2/YOR037C, and the cloned FDD fragment (YPR036W-A).
C: Strand-speci¢c RT-PCR assay for YPR036W-A. Each strand-
speci¢c cDNA was synthesized by RT with each anti-sense primer,
and subjected to PCR. The expected product was obtained only
when cDNA for the Watson strand was used as template for PDR.
D: Structure of YPR036W-A. The transcribed region is shaded in
black, and the small putative ORF is underlined. The potential
PDRE are shaded in gray, and putative TATA-like sequences are
underlined. The £anking ORFs are also indicated.
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(TCCGCGGA) at its 3341 position (Fig. 3D). We thus tested
whether or not this element regulates the expression of this
gene. At ¢rst, we constructed lacZ reporter plasmid constructs
bearing YPR036W-A promoter with or without the PDRE-
like sequence, and introduced them into the three strains with
di¡erential Pdr1p-activities used in the FDD analysis. The
construct bearing the PDRE-like sequence conferred higher
lacZ activity in the PDR1-3 strain than in others (Fig. 4A).
In contrast, when transformed with the construct lacking the
sequence, the PDR1-3 strain failed to display higher lacZ
activity than other strains (Fig. 4A).
Next, we intended to examine whether this sequence func-
tions as a PDRE in the context of natural genome sequence.
For this purpose, we expressed null allele (control vector),
PDR1, or PDR1-3 from a low-copy plasmid in pdr1v strains
bearing or lacking the PDRE-like sequence, and compared the
expression patterns of YPR036W-A. As shown in Fig. 4B, the
expression level of YPR036W-A was well correlated with
Pdr1p activity in the strain bearing the intact PDRE-like se-
quence, whereas such dependence was not observed at all in
the strain lacking the element (Fig. 4B).
Taken together, these results indicate that the expression of
YPR036W-A is regulated by the upstream PDRE-like se-
quence: the sequence does function as a PDRE. While the
predicted product of this ORF shows marginal homologies
to hypothetical proteins in ¢ssion yeast and nematodes (not
shown), it remains elusive whether this ORF indeed encodes a
protein related to multidrug resistance. E¡orts to pursue this
possibility are currently under way.
3.6. Conclusions
Di¡erential display analysis of PDR1 mutants revealed can-
didates for novel target genes of this transcription factor,
which include a previously unrecognized transcription unit
bearing a small putative ORF with a functional upstream
PDRE. While message display PCR and serial analyses of
gene expression are slower and less comprehensive than mi-
croarray in analyzing transcriptome, they can notably reveal
novel small genes that were overlooked in the standard anno-
tation of the genome sequence [29]. Identi¢cation of such
genes is a prerequisite for truly comprehensive transcriptome
analysis, and hence, for deciphering the yeast genome.
Acknowledgements: We thank Andre Go¡eau for yeast strains and
encouragement. This work was supported by research grants from
Japan Society for the Promotion of Sciences (JSPS) and the Ministry
of Education, Culture, Sports, Science and Technology (MEXT) of
Japan.
References
[1] Balzi, E. and Go¡eau, A. (1995) J. Bioenerg. Biomembr. 27, 71^
76.
[2] Balzi, E, Chen, W., Ulaszewski, S., Capieaux, E. and Go¡eau, A.
(1987) J. Biol. Chem. 262, 16871^16879.
[3] Delaveau, T., Delahodde, A., Carvajal, E., Subik, J. and Jacq, C.
(1994) Mol. Gen. Genet. 244, 501^511.
[4] Katzmann, D.J., Hallstrom, T.C., Mahe, Y. and Moye-Rowley,
W.S. (1996) J. Biol. Chem. 271, 23049^23054.
[5] Katzmann, D.J., Burnett, P.E., Golin, J., Mahe, Y. and Moye-
Rowley, W.S. (1994) Mol. Cell. Biol. 14, 4653^4661.
[6] Delahodde, A., Delaveau, T. and Jacq, C. (1995) Mol. Cell. Biol.
15, 4043^4051.
[7] Mahe, Y., Parle-McDermott, A., Nourani, A., Delahodde, A.,
Lamprecht, A. and Kuchler, K. (1996) Mol. Microbiol. 20,
109^117.
[8] Nourani, A., Wesolowski-Louvel, M., Delaveau, T., Jacq, C. and
Delahodde, A. (1997) Mol. Cell. Biol. 17, 5453^5460.
[9] Wolfger, H., Mahe, Y., Parle-McDermott, A., Delahodde, A.
and Kuchler, K. (1997) FEBS Lett. 418, 269^274.
[10] Hallstrom, T.C. and Moye-Rowley, W.S. (1998) J. Biol. Chem.
273, 2098^2104.
[11] Balzi, E., Wang, M., Leterme, S., Van Dyck, L. and Go¡eau, A.
(1994) J. Biol. Chem. 269, 2206^2214.
[12] Servos, J., Haase, E. and Brendel, M. (1993) Mol. Gen. Genet.
236, 214^218.
[13] Decottignies, A., Lambert, L., Catty, P., Degand, H., Epping,
E.A., Moye-Rowley, W.S., Balzi, E. and Go¡eau, A. (1995)
J. Biol. Chem. 270, 18150^18157.
[14] Katzmann, D.J., Hallstrom, T.C., Voet, M., Wysock, W., Golin,
J., Volckaert, G. and Moye-Rowley, W.S. (1995) Mol. Cell. Biol.
15, 6875^6883.
[15] Decottignies, A., Grant, A.M., Nichols, J.W., de Wet, H., Mc-
Intosh, D.B. and Go¡eau, A. (1998) J. Biol. Chem. 273, 12612^
12622.
[16] Carvajal, E., van den Hazel, H.B., Cybularz-Kolaczkowska, A.,
Balzi, E. and Go¡eau, A. (1997) Mol. Gen. Genet. 256, 406^
415.
Fig. 4. Regulated expression of YPR036W-A by PDRE and Pdr1p.
A: Using two lacZ reporter constructs (pRS41K-YPR036W-A-lacZ
and pRS41K-YPR036W-A-PDREv-lacZ), activity of YPR036W-A
promoter with or without the PDRE-like sequence was measured in
strains bearing PDR1, pdr1v and PDR1-3. B: The expression of
YPR036W-A was examined in FY1679-28C/TDEC (pdr1v, pdr3v),
which bears the PDRE, and in FY1679-28Cd/TDEC (pdr1v, pdr3v,
YPR036W-A-PDREv), which lacks the PDRE, each bearing control
vector, PDR1 or PDR1-3 plasmid. The top and bottom panels show
the results of RT-PCR for YPR036W-A and PDC1 (control), re-
spectively.
FEBS 25198 4-9-01
F. Miura et al./FEBS Letters 505 (2001) 103^108 107
[17] Schmitt, M.E., Brown, T.A. and Trumpower, B.L. (1990) Nucleic
Acids Res. 18, 3091^3092.
[18] Ito, T., Kito, K., Adati, N., Mitsui, Y., Hagiwara, H. and Saka-
ki, Y. (1994) FEBS Lett. 351, 231^236.
[19] Ito, T. and Sakaki, Y. (1997) Methods Mol. Biol. 85, 37^44.
[20] Ito, T. and Sakaki, Y. (1999) Methods Enzymol. 303, 298^309.
[21] Kato, K. (1997) Nucleic Acids Res. 25, 4694^4696.
[22] Yada, T., Totoki, Y., Ishikawa, M., Asai, K. and Nakai, K.
(1998) Bioinformatics 14, 317^325.
[23] Kito, K., Ito, T. and Sakaki, Y. (1997) Gene 184, 73^81.
[24] Kubota, H., Ota, K., Sakaki, Y. and Ito, T. (2001) J. Biol. Chem.
276, 17591^17596.
[25] van den Hazel, H.B., Pichler, H., Matta, M.A.V., Leitner, E.,
Go¡eau, A. and Daum, G. (1999) J. Biol. Chem. 274, 1934^
1941.
[26] Iyer, V.R., Horak, S.E., Scafe, C.S., Botstein, D., Snyder, M. and
Brown, P.O. (2001) Nature 409, 533^538.
[27] DeRisi, J., van der Henzel, B., Marc, P., Balzi, E., Brown, P.,
Jacq, C. and Go¡eau, A. (2000) FEBS Lett. 470, 156^160.
[28] Devaux, F., Marc, P., Bouchoux, C., Delaveau, T., Hikkel, I.,
Potier, M.-C. and Jacq, C. (2001) EMBO Rep. 2, 493^498.
[29] Velculescu, V.E., Zhang, L., Zhou, W., Vogelstein, J., Basrai,
M.A., Bassett Jr., D.E., Hieter, P., Vogelstein, B. and Kinzler,
K.W. (1997) Cell 88, 243^251.
FEBS 25198 4-9-01
F. Miura et al./FEBS Letters 505 (2001) 103^108108
